CLINICAL_TRIALS
trial_result
· 2022-10-06
Clinical Trial Update: Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis [Phase 4]
Summary
A Phase 4 clinical trial evaluating cytokine-guided risk stratification and treatment for pediatric hemophagocytic lymphohistiocytosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Hemophagocytic Lymphohistiocytoses, Cytokine Storm | Phase 4 | Status: UNKNOWN